|4Dec 10, 4:51 PM ET

Dunn Gordon 4

4 · Quoin Pharmaceuticals, Ltd. · Filed Dec 10, 2024

Insider Transaction Report

Form 4
Period: 2024-12-09
Dunn Gordon
Chief Financial Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2024-12-09+338,994338,994 total
    Exercise: $0.78Exp: 2034-12-09ADS (338,994 underlying)
Footnotes (2)
  • [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
  • [F2]The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028.

Documents

1 file
  • 4
    tm2430519-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT